Buprenorphine prescribing practices and exposures reported to a poison center - Utah, 2002-2011

Morbidity and Mortality Weekly Report

Volumn 61, Issue 49, 2012, Pages 997-1001

  Thomas, Karen C ^a   Malheiro, Marty ^a   Crouch, Barbara I ^a   Porucznik, Christina A ^b  

^a Utah Poison Control Center   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; NARCOTIC ANTAGONIST;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; CHILD; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG MISUSE; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; OPIATE ADDICTION; POISON CENTER; PRESCHOOL CHILD; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; BUPRENORPHINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; POISON CONTROL CENTERS; PRESCRIPTION DRUG MISUSE; UTAH; YOUNG ADULT;

EID: 84871481067     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Emmanuelli J, Desenclos JC. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction 2005;100:1690-1700.
2. CDC. CDC grand rounds: prescription drug overdoses-a U.S. epidemic. MMWR 2012;61:10-3.
3. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev 2009;3:CD002025.
4. Sporer KA. Buprenorphine: a primer for emergency physicians. Ann Emerg Med 2004;43:580-4.
5. Mendelson J, Flower K, Pletcher MJ, Galloway GP. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine. Exp Clin Psychopharmacol 2008;16:435-41.
6. Pedapati EV, Bateman ST. Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone. Pediatr Crit Care Med 2011;12:e102-7.
7. Durback-Morris LF, Scharman EJ. Are children the unintended victims of changes in buprenorphine prescribing practices [Abstract]? Clin Toxicol 2010;48:616.
8. Lofwall MR, Havens JR. Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine. Drug Alcohol Depend 2012;126:379-83.
9. Kresina TF, Lubran R. Improving public health through access to and utilization of medication assisted treatment. Int J Environ Res Public Health 2011;8:4102-17.